Related Experiment Video
Updated: Jan 28, 2026

A Retrospective Study on Endoscopic Surgery for the Treatment of Paravertebral Abscess in Spinal Tuberculosis Patients
Published on: October 25, 2024
Pilot Study to Evaluate the Adjunct Use of a Povidone-Iodine Topical Antiseptic in Patients with Soft Tissue
Adriana Segura Olson1, Lauren Rosenblatt2, Nicholas Salerno2
1Department of Medicine, Section of Emergency Medicine, University of Chicago, Chicago, Illinois.
Background:
Povidone-iodine (PVP-I) antiseptic solutions have been shown to be effective against methicillin-resistant Staphylococcal aureus, a common cause of superficial skin abscesses.
Objectives:
Our objective was to study the feasibility of using PVP-I as a treatment adjunct in patients with superficial skin abscesses and determine if it confers any benefit over incision and drainage (I&D) alone.
Methods:
This was a randomized controlled pilot study of adult patients with an uncomplicated skin abscess. Patients were randomized to PVP-I or standard treatment. All patients had I&D and abscess packing. Patients randomized to PVP-I were instructed on daily application of the agent to hands, wound, and surrounding skin with dressing changes. Subjects returned at 48-72 h and 7-10 days and followed-up by phone at 30 days. The primary outcome was clinical cure 7-10 days after I&D. The secondary outcomes were rate of development of new skin lesions and spread in household contacts within 30 days.
Results:
Clinical cure occurred in 91.3% of patients in the standard group vs. 88.2% of patients in the PVP-I group (difference, 3.1%; 95% confidence interval [CI] -10.7 to 16.8; p = 0.53). There was a significantly higher adverse event rate in the group who received PVP-I (59.6%) vs. standard care (26.5%) (difference 33.1%, 95% CI 13.2-50.2; p < 0.001).
Conclusions:
There was no difference in clinical cure rates among patients using PVP-I (88.2%) vs. standard care (91.3%) after I&D. There were no major adverse events, but the addition of PVP-I was commonly associated with local skin irritation.
Insights
Povidone-iodine (PVP-I) did not improve clinical cure rates for skin abscesses compared to standard care. The addition of PVP-I was associated with a higher rate of local skin irritation.
Area of Science:
- Dermatology
- Infectious Diseases
- Clinical Research
Background:
- Povidone-iodine (PVP-I) exhibits efficacy against methicillin-resistant Staphylococcus aureus (MRSA).
- MRSA is a frequent cause of superficial skin abscesses.
Purpose of the Study:
- To assess the feasibility of using PVP-I as an adjunctive treatment for superficial skin abscesses.
- To compare the efficacy of PVP-I plus incision and drainage (I&D) against I&D alone.
Main Methods:
- A randomized controlled pilot study was conducted on adult patients with uncomplicated skin abscesses.
- Patients received either PVP-I adjunct therapy or standard care, alongside I&D and abscess packing.
- Outcomes included clinical cure rates at 7-10 days and secondary assessments of new lesions and household contact spread.
Main Results:
- Clinical cure rates were similar between the PVP-I group (88.2%) and the standard care group (91.3%).
- The PVP-I group experienced a significantly higher incidence of adverse events (59.6%) compared to standard care (26.5%).
- Local skin irritation was a common adverse event associated with PVP-I use.
Conclusions:
- PVP-I does not offer a clinical cure benefit when used as an adjunct to I&D for skin abscesses.
- While no major adverse events were reported, PVP-I use led to increased local skin irritation.
- Standard care remains the recommended treatment approach for uncomplicated skin abscesses.
More Related Videos
Related Concept Videos
Pilot and Numeric Relaying
Heart Failure VI: Adjunct Therapies
Electrophilic Aromatic Substitution: Fluorination and Iodination of Benzene
Nursing Process for Patient and Caregiver Teaching III: Evaluation and Documentation
Nurses can use several methods to evaluate patient outcomes. For example, oral questions can assess cognitive learning,...
Bioavailability Study Design: Healthy Subjects Versus Patients
Patient-centered Care

